These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 12587118)
1. Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice. Iizasa H; Genda N; Kitano T; Tomita M; Nishihara K; Hayashi M; Nakamura K; Kobayashi S; Nakashima E J Pharm Sci; 2003 Mar; 92(3):569-76. PubMed ID: 12587118 [TBL] [Abstract][Full Text] [Related]
2. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687 [TBL] [Abstract][Full Text] [Related]
3. Xanthorrhizol attenuates dextran sulfate sodium-induced colitis via the modulation of the expression of inflammatory genes in mice. Cho JY; Hwang JK; Chun HS Life Sci; 2011 May; 88(19-20):864-70. PubMed ID: 21419136 [TBL] [Abstract][Full Text] [Related]
4. Alanyl-glutamine administration suppresses Th17 and reduces inflammatory reaction in dextran sulfate sodium-induced acute colitis. Hou YC; Liu JJ; Pai MH; Tsou SS; Yeh SL Int Immunopharmacol; 2013 Sep; 17(1):1-8. PubMed ID: 23721689 [TBL] [Abstract][Full Text] [Related]
5. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis. Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101 [TBL] [Abstract][Full Text] [Related]
8. Role of metallothionein in murine experimental colitis. Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis. Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis. Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582 [TBL] [Abstract][Full Text] [Related]
11. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum. Yao J; Wang JY; Lai MG; Li YX; Zhu HM; Shi RY; Mo J; Xun AY; Jia CH; Feng JL; Wang LS; Zeng WS; Liu L Mol Pharm; 2011 Apr; 8(2):488-97. PubMed ID: 21271712 [TBL] [Abstract][Full Text] [Related]
12. PPARα contributes to colonic protection in mice with DSS-induced colitis. Azuma YT; Nishiyama K; Matsuo Y; Kuwamura M; Morioka A; Nakajima H; Takeuchi T Int Immunopharmacol; 2010 Oct; 10(10):1261-7. PubMed ID: 20650341 [TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Cooper HS; Murthy SN; Shah RS; Sedergran DJ Lab Invest; 1993 Aug; 69(2):238-49. PubMed ID: 8350599 [TBL] [Abstract][Full Text] [Related]
16. Changes of CD8⁺ T cells in dextran sulfate sodium-induced colitis mice pretreated with oral immune regulation. Ye YF; Jin X; Chen SH; Yue M; Li YM Chin Med J (Engl); 2012 Jun; 125(12):2173-9. PubMed ID: 22884149 [TBL] [Abstract][Full Text] [Related]
17. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. Gao Y; Li X; Yang M; Zhao Q; Liu X; Wang G; Lu X; Wu Q; Wu J; Yang Y; Yang Y; Zhang Y Carcinogenesis; 2013 Aug; 34(8):1861-9. PubMed ID: 23615396 [TBL] [Abstract][Full Text] [Related]
18. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease. Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091 [TBL] [Abstract][Full Text] [Related]
19. Heligmosmoides polygyrus fourth stages induce protection against DSS-induced colitis and change opioid expression in the intestine. Donskow-Łysoniewska K; Majewski P; Brodaczewska K; Jóźwicka K; Doligalska M Parasite Immunol; 2012 Nov; 34(11):536-46. PubMed ID: 22889318 [TBL] [Abstract][Full Text] [Related]
20. Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1 beta and insulin-like growth factor I messenger ribonucleic acid. Sävendahl L; Underwood LE; Haldeman KM; Ulshen MH; Lund PK Endocrinology; 1997 Feb; 138(2):734-40. PubMed ID: 9003009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]